Factors associated with hospital admission and severe outcomes for older patients with COVID-19.
COVID-19
age-specific risk factors
ambulatory care
community-living older adults
Journal
Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
revised:
20
01
2022
received:
12
10
2021
accepted:
06
02
2022
pubmed:
19
2
2022
medline:
16
7
2022
entrez:
18
2
2022
Statut:
ppublish
Résumé
Morbidity and death due to coronavirus disease 2019 (COVID-19) experienced by older adults in nursing homes have been well described, but COVID-19's impact on community-living older adults is less studied. Similarly, the previous ambulatory care experience of such patients has rarely been considered in studies of COVID-19 risks and outcomes. To investigate the relationship of advanced age (65+), on risk factors associated with COVID-19 outcomes in community-living elders, we identified an electronic health records cohort of older patients aged 65+ with laboratory-confirmed COVID-19 with and without an ambulatory care visit in the past 24 months (n = 47,219) in the New York City (NYC) academic medical institutions and the NYC public hospital system from January 2020 to February 2021. The main outcomes are COVID-19 hospitalization; severe outcomes/Intensive care unit (ICU), intubation, dialysis, stroke, in-hospital death), and in-hospital death. The exposures include demographic characteristics, and those with ambulatory records, comorbidities, frailty, and laboratory results. The 31,770 patients with an ambulatory history had a median age of 74 years; were 47.4% male, 24.3% non-Hispanic white, 23.3% non-Hispanic black, and 18.4% Hispanic. With increasing age, the odds ratios and attributable fractions of sex, race-ethnicity, comorbidities, and biomarkers decreased except for dementia and frailty (Hospital Frailty Risk Score). Patients without ambulatory care histories, compared to those with, had significantly higher adjusted rates of COVID-19 hospitalization and severe outcomes, with strongest effect in the oldest group. In this cohort of community-dwelling older adults, we provided evidence of age-specific risk factors for COVID-19 hospitalization and severe outcomes. Future research should explore the impact of frailty and dementia in severe COVID-19 outcomes in community-living older adults, and the role of engagement in ambulatory care in mitigating severe disease.
Sections du résumé
BACKGROUND
Morbidity and death due to coronavirus disease 2019 (COVID-19) experienced by older adults in nursing homes have been well described, but COVID-19's impact on community-living older adults is less studied. Similarly, the previous ambulatory care experience of such patients has rarely been considered in studies of COVID-19 risks and outcomes.
METHODS
To investigate the relationship of advanced age (65+), on risk factors associated with COVID-19 outcomes in community-living elders, we identified an electronic health records cohort of older patients aged 65+ with laboratory-confirmed COVID-19 with and without an ambulatory care visit in the past 24 months (n = 47,219) in the New York City (NYC) academic medical institutions and the NYC public hospital system from January 2020 to February 2021. The main outcomes are COVID-19 hospitalization; severe outcomes/Intensive care unit (ICU), intubation, dialysis, stroke, in-hospital death), and in-hospital death. The exposures include demographic characteristics, and those with ambulatory records, comorbidities, frailty, and laboratory results.
RESULTS
The 31,770 patients with an ambulatory history had a median age of 74 years; were 47.4% male, 24.3% non-Hispanic white, 23.3% non-Hispanic black, and 18.4% Hispanic. With increasing age, the odds ratios and attributable fractions of sex, race-ethnicity, comorbidities, and biomarkers decreased except for dementia and frailty (Hospital Frailty Risk Score). Patients without ambulatory care histories, compared to those with, had significantly higher adjusted rates of COVID-19 hospitalization and severe outcomes, with strongest effect in the oldest group.
CONCLUSIONS
In this cohort of community-dwelling older adults, we provided evidence of age-specific risk factors for COVID-19 hospitalization and severe outcomes. Future research should explore the impact of frailty and dementia in severe COVID-19 outcomes in community-living older adults, and the role of engagement in ambulatory care in mitigating severe disease.
Identifiants
pubmed: 35179781
doi: 10.1111/jgs.17718
pmc: PMC9115084
mid: NIHMS1781758
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1906-1917Subventions
Organisme : NIA NIH HHS
ID : R01 AG054467
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG065330
Pays : United States
Organisme : NLM NIH HHS
ID : R01 LM013344
Pays : United States
Informations de copyright
© 2022 The American Geriatrics Society.
Références
J Am Med Dir Assoc. 2020 Nov;21(11):1546-1554.e3
pubmed: 33138936
Am J Epidemiol. 1985 Nov;122(5):904-14
pubmed: 4050778
J Infect. 2020 Aug;81(2):e16-e25
pubmed: 32335169
Eur Geriatr Med. 2021 Jun;12(3):601-607
pubmed: 33245505
J Am Med Dir Assoc. 2020 Oct;21(10):1378-1383.e1
pubmed: 32981664
MMWR Morb Mortal Wkly Rep. 2021 Apr 16;70(15):560-565
pubmed: 33857068
J Prim Care Community Health. 2017 Jul;8(3):169-175
pubmed: 28606031
Annu Rev Public Health. 1999;20:89-108
pubmed: 10352851
MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1725-1729
pubmed: 33211680
J Am Geriatr Soc. 2022 Jul;70(7):1906-1917
pubmed: 35179781
J Am Geriatr Soc. 2020 Jun;68(6):E19-E23
pubmed: 32383809
J Infect. 2020 Jun;80(6):e14-e18
pubmed: 32171866
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
Lancet. 2018 May 5;391(10132):1775-1782
pubmed: 29706364
JAMA Intern Med. 2021 Apr 1;181(4):439-448
pubmed: 33394006
J Am Geriatr Soc. 2020 May;68(5):926-929
pubmed: 32255507
Int J Infect Dis. 2021 Jan;102:415-421
pubmed: 33130213
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
JAMA Netw Open. 2020 Sep 1;3(9):e2022310
pubmed: 32965502
Sci Rep. 2021 Feb 18;11(1):4200
pubmed: 33603086
Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):1899-1913
pubmed: 32912793
J Am Med Inform Assoc. 2014 Jul-Aug;21(4):587-90
pubmed: 24821739
J Am Med Dir Assoc. 2020 Jul;21(7):928-932.e1
pubmed: 32674821
BMJ. 2020 May 22;369:m1966
pubmed: 32444366
J Med Internet Res. 2020 Nov 11;22(11):e23128
pubmed: 33035175
Rev Saude Publica. 2020;54:60
pubmed: 32491116
JAMA Intern Med. 2020 Nov 1;180(11):1436-1447
pubmed: 32667668
JAMA Intern Med. 2018 Nov 1;178(11):1544-1547
pubmed: 30128552